Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+10.7M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$573M
-
Put/Call ratio
-
0.88
-
Number of buys
-
50
-
Number of sells
-
-33
-
Price
-
$50.56
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q3 2021
110 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q3 2021.
Legend Biotech Corp - COMMON STOCK (LEGN) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 367M outstanding shares and own 10.62% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (11.1M shares), Capital International Investors (2.69M shares), BAKER BROS. ADVISORS LP (2.36M shares), ALLIANCEBERNSTEIN L.P. (2M shares), CAPITAL INTERNATIONAL INC /CA/ (1.92M shares), Hudson Bay Capital Management LP (1.88M shares), FEDERATED HERMES, INC. (1.77M shares), JOHNSON & JOHNSON (1.63M shares), Woodline Partners LP (1.48M shares), and MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1.36M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.